id	sid	tid	token	lemma	pos
ajbspi-34519	1	1	volume	volume	NOUN
ajbspi-34519	1	2	04	04	NUM
ajbspi-34519	1	3	issue	issue	NOUN
ajbspi-34519	1	4	05	05	NUM
ajbspi-34519	1	5	-	-	SYM
ajbspi-34519	1	6	2024	2024	NUM
ajbspi-34519	1	7	19	19	NUM
ajbspi-34519	1	8	american	american	ADJ
ajbspi-34519	1	9	journal	journal	PROPN
ajbspi-34519	1	10	of	of	ADP
ajbspi-34519	1	11	biomedical	biomedical	PROPN
ajbspi-34519	1	12	science	science	PROPN
ajbspi-34519	1	13	&	&	CCONJ
ajbspi-34519	1	14	pharmaceutical	pharmaceutical	PROPN
ajbspi-34519	1	15	innovation	innovation	NOUN
ajbspi-34519	1	16	(	(	PUNCT
ajbspi-34519	1	17	issn	issn	PROPN
ajbspi-34519	1	18	–	–	PUNCT
ajbspi-34519	1	19	2771	2771	NUM
ajbspi-34519	1	20	-	-	SYM
ajbspi-34519	1	21	2753	2753	NUM
ajbspi-34519	1	22	)	)	PUNCT
ajbspi-34519	1	23	volume	volume	NOUN
ajbspi-34519	1	24	04	04	NUM
ajbspi-34519	1	25	issue	issue	NOUN
ajbspi-34519	1	26	05	05	NUM
ajbspi-34519	1	27	pages	page	NOUN
ajbspi-34519	1	28	:	:	PUNCT
ajbspi-34519	1	29	19	19	NUM
ajbspi-34519	1	30	-	-	SYM
ajbspi-34519	1	31	21	21	NUM
ajbspi-34519	1	32	sjif	sjif	NOUN
ajbspi-34519	1	33	impact	impact	NOUN
ajbspi-34519	1	34	factor	factor	NOUN
ajbspi-34519	1	35	(	(	PUNCT
ajbspi-34519	1	36	2022	2022	NUM
ajbspi-34519	1	37	:	:	PUNCT
ajbspi-34519	1	38	5	5	NUM
ajbspi-34519	1	39	.	.	NOUN
ajbspi-34519	1	40	705	705	NUM
ajbspi-34519	1	41	)	)	PUNCT
ajbspi-34519	1	42	(	(	PUNCT
ajbspi-34519	1	43	2023	2023	NUM
ajbspi-34519	1	44	:	:	PUNCT
ajbspi-34519	1	45	6.534	6.534	NUM
ajbspi-34519	1	46	)	)	PUNCT
ajbspi-34519	1	47	(	(	PUNCT
ajbspi-34519	1	48	2024	2024	NUM
ajbspi-34519	1	49	:	:	PUNCT
ajbspi-34519	1	50	7.7	7.7	NUM
ajbspi-34519	1	51	)	)	PUNCT
ajbspi-34519	1	52	oclc	oclc	PROPN
ajbspi-34519	1	53	–	–	PUNCT
ajbspi-34519	1	54	1121105677	1121105677	NUM
ajbspi-34519	1	55	publisher	publisher	NOUN
ajbspi-34519	1	56	:	:	PUNCT
ajbspi-34519	2	1	oscar	oscar	NOUN
ajbspi-34519	2	2	publishing	publishing	NOUN
ajbspi-34519	2	3	services	service	NOUN
ajbspi-34519	2	4	servi	servi	PROPN
ajbspi-34519	2	5	abstract	abstract	ADJ
ajbspi-34519	2	6	biotransformation	biotransformation	NOUN
ajbspi-34519	2	7	enzyme	enzyme	NOUN
ajbspi-34519	2	8	genes	gene	NOUN
ajbspi-34519	2	9	play	play	VERB
ajbspi-34519	2	10	an	an	DET
ajbspi-34519	2	11	important	important	ADJ
ajbspi-34519	2	12	role	role	NOUN
ajbspi-34519	2	13	in	in	ADP
ajbspi-34519	2	14	metabolism	metabolism	NOUN
ajbspi-34519	2	15	and	and	CCONJ
ajbspi-34519	2	16	processing	processing	NOUN
ajbspi-34519	2	17	of	of	ADP
ajbspi-34519	2	18	foreign	foreign	ADJ
ajbspi-34519	2	19	substances	substance	NOUN
ajbspi-34519	2	20	(	(	PUNCT
ajbspi-34519	2	21	xenobiotics	xenobiotic	NOUN
ajbspi-34519	2	22	)	)	PUNCT
ajbspi-34519	2	23	in	in	ADP
ajbspi-34519	2	24	the	the	DET
ajbspi-34519	2	25	body	body	NOUN
ajbspi-34519	2	26	.	.	PUNCT
ajbspi-34519	3	1	their	their	PRON
ajbspi-34519	3	2	role	role	NOUN
ajbspi-34519	3	3	in	in	ADP
ajbspi-34519	3	4	tumor	tumor	NOUN
ajbspi-34519	3	5	progression	progression	NOUN
ajbspi-34519	3	6	is	be	AUX
ajbspi-34519	3	7	their	their	PRON
ajbspi-34519	3	8	ability	ability	NOUN
ajbspi-34519	3	9	to	to	PART
ajbspi-34519	3	10	modulate	modulate	VERB
ajbspi-34519	3	11	metabolic	metabolic	NOUN
ajbspi-34519	3	12	pathways	pathway	NOUN
ajbspi-34519	3	13	by	by	ADP
ajbspi-34519	3	14	affecting	affect	VERB
ajbspi-34519	3	15	the	the	DET
ajbspi-34519	3	16	processing	processing	NOUN
ajbspi-34519	3	17	of	of	ADP
ajbspi-34519	3	18	xenobiotics	xenobiotic	NOUN
ajbspi-34519	3	19	,	,	PUNCT
ajbspi-34519	3	20	which	which	PRON
ajbspi-34519	3	21	may	may	AUX
ajbspi-34519	3	22	affect	affect	VERB
ajbspi-34519	3	23	the	the	DET
ajbspi-34519	3	24	development	development	NOUN
ajbspi-34519	3	25	of	of	ADP
ajbspi-34519	3	26	tumors	tumor	NOUN
ajbspi-34519	3	27	.	.	PUNCT
ajbspi-34519	4	1	this	this	PRON
ajbspi-34519	4	2	is	be	AUX
ajbspi-34519	4	3	a	a	DET
ajbspi-34519	4	4	current	current	ADJ
ajbspi-34519	4	5	topic	topic	NOUN
ajbspi-34519	4	6	of	of	ADP
ajbspi-34519	4	7	research	research	NOUN
ajbspi-34519	4	8	in	in	ADP
ajbspi-34519	4	9	the	the	DET
ajbspi-34519	4	10	field	field	NOUN
ajbspi-34519	4	11	of	of	ADP
ajbspi-34519	4	12	oncology	oncology	NOUN
ajbspi-34519	4	13	.	.	PUNCT
ajbspi-34519	5	1	keywords	keyword	VERB
ajbspi-34519	5	2	acute	acute	ADJ
ajbspi-34519	5	3	leukemia	leukemia	NOUN
ajbspi-34519	5	4	,	,	PUNCT
ajbspi-34519	5	5	chronic	chronic	ADJ
ajbspi-34519	5	6	leukemia	leukemia	NOUN
ajbspi-34519	5	7	,	,	PUNCT
ajbspi-34519	5	8	molecular	molecular	ADJ
ajbspi-34519	5	9	genetics	genetic	NOUN
ajbspi-34519	5	10	,	,	PUNCT
ajbspi-34519	5	11	gene	gene	NOUN
ajbspi-34519	5	12	,	,	PUNCT
ajbspi-34519	5	13	polymorphism	polymorphism	NOUN
ajbspi-34519	5	14	,	,	PUNCT
ajbspi-34519	5	15	heterozygosity	heterozygosity	NOUN
ajbspi-34519	5	16	,	,	PUNCT
ajbspi-34519	5	17	wild	wild	ADJ
ajbspi-34519	5	18	allele	allele	NOUN
ajbspi-34519	5	19	,	,	PUNCT
ajbspi-34519	5	20	minor	minor	ADJ
ajbspi-34519	5	21	allele	allele	NOUN
ajbspi-34519	5	22	,	,	PUNCT
ajbspi-34519	5	23	mdr1	mdr1	PROPN
ajbspi-34519	5	24	,	,	PUNCT
ajbspi-34519	5	25	rs1045642	rs1045642	PROPN
ajbspi-34519	5	26	.	.	PUNCT
ajbspi-34519	6	1	introduction	introduction	NOUN
ajbspi-34519	6	2	the	the	DET
ajbspi-34519	6	3	mdr1	mdr1	PROPN
ajbspi-34519	6	4	gene	gene	NOUN
ajbspi-34519	6	5	encodes	encode	VERB
ajbspi-34519	6	6	a	a	DET
ajbspi-34519	6	7	protein	protein	NOUN
ajbspi-34519	6	8	called	call	VERB
ajbspi-34519	6	9	pglycoprotein	pglycoprotein	ADV
ajbspi-34519	6	10	(	(	PUNCT
ajbspi-34519	6	11	p	p	NOUN
ajbspi-34519	6	12	-	-	PUNCT
ajbspi-34519	6	13	gp	gp	NOUN
ajbspi-34519	6	14	)	)	PUNCT
ajbspi-34519	6	15	,	,	PUNCT
ajbspi-34519	6	16	which	which	PRON
ajbspi-34519	6	17	is	be	AUX
ajbspi-34519	6	18	a	a	DET
ajbspi-34519	6	19	member	member	NOUN
ajbspi-34519	6	20	of	of	ADP
ajbspi-34519	6	21	the	the	DET
ajbspi-34519	6	22	atpbinding	atpbinding	NOUN
ajbspi-34519	6	23	cassette	cassette	NOUN
ajbspi-34519	6	24	(	(	PUNCT
ajbspi-34519	6	25	abc	abc	PROPN
ajbspi-34519	6	26	)	)	PUNCT
ajbspi-34519	6	27	transporter	transporter	NOUN
ajbspi-34519	6	28	family	family	NOUN
ajbspi-34519	6	29	.	.	PUNCT
ajbspi-34519	7	1	p	p	X
ajbspi-34519	7	2	-	-	PUNCT
ajbspi-34519	7	3	gp	gp	NOUN
ajbspi-34519	7	4	plays	play	VERB
ajbspi-34519	7	5	a	a	DET
ajbspi-34519	7	6	critical	critical	ADJ
ajbspi-34519	7	7	role	role	NOUN
ajbspi-34519	7	8	in	in	ADP
ajbspi-34519	7	9	cellular	cellular	ADJ
ajbspi-34519	7	10	drug	drug	NOUN
ajbspi-34519	7	11	efflux	efflux	NOUN
ajbspi-34519	7	12	,	,	PUNCT
ajbspi-34519	7	13	actively	actively	ADV
ajbspi-34519	7	14	pumping	pump	VERB
ajbspi-34519	7	15	various	various	ADJ
ajbspi-34519	7	16	drugs	drug	NOUN
ajbspi-34519	7	17	and	and	CCONJ
ajbspi-34519	7	18	toxins	toxin	NOUN
ajbspi-34519	7	19	out	out	ADP
ajbspi-34519	7	20	of	of	ADP
ajbspi-34519	7	21	cells	cell	NOUN
ajbspi-34519	7	22	,	,	PUNCT
ajbspi-34519	7	23	thereby	thereby	ADV
ajbspi-34519	7	24	promoting	promote	VERB
ajbspi-34519	7	25	drug	drug	NOUN
ajbspi-34519	7	26	resistance	resistance	NOUN
ajbspi-34519	7	27	in	in	ADP
ajbspi-34519	7	28	cancer	cancer	NOUN
ajbspi-34519	7	29	treatment	treatment	NOUN
ajbspi-34519	7	30	.	.	PUNCT
ajbspi-34519	8	1	the	the	DET
ajbspi-34519	8	2	research	research	NOUN
ajbspi-34519	8	3	article	article	NOUN
ajbspi-34519	8	4	role	role	NOUN
ajbspi-34519	8	5	of	of	ADP
ajbspi-34519	8	6	the	the	DET
ajbspi-34519	8	7	gene	gene	NOUN
ajbspi-34519	8	8	for	for	ADP
ajbspi-34519	8	9	xenobiotics	xenobiotics	PROPN
ajbspi-34519	8	10	biotransformation	biotransformation	NOUN
ajbspi-34519	8	11	enzyme	enzyme	NOUN
ajbspi-34519	8	12	in	in	ADP
ajbspi-34519	8	13	tumor	tumor	NOUN
ajbspi-34519	8	14	progression	progression	NOUN
ajbspi-34519	8	15	in	in	ADP
ajbspi-34519	8	16	acute	acute	ADJ
ajbspi-34519	8	17	leukemia	leukemia	NOUN
ajbspi-34519	8	18	submission	submission	NOUN
ajbspi-34519	8	19	date	date	NOUN
ajbspi-34519	8	20	:	:	PUNCT
ajbspi-34519	8	21	may	may	AUX
ajbspi-34519	8	22	07	07	NUM
ajbspi-34519	8	23	,	,	PUNCT
ajbspi-34519	8	24	2024	2024	NUM
ajbspi-34519	8	25	,	,	PUNCT
ajbspi-34519	8	26	accepted	accept	VERB
ajbspi-34519	8	27	date	date	NOUN
ajbspi-34519	8	28	:	:	PUNCT
ajbspi-34519	8	29	may	may	AUX
ajbspi-34519	8	30	12	12	NUM
ajbspi-34519	8	31	,	,	PUNCT
ajbspi-34519	8	32	2024	2024	NUM
ajbspi-34519	8	33	,	,	PUNCT
ajbspi-34519	8	34	published	publish	VERB
ajbspi-34519	8	35	date	date	NOUN
ajbspi-34519	8	36	:	:	PUNCT
ajbspi-34519	8	37	may	may	AUX
ajbspi-34519	8	38	17	17	NUM
ajbspi-34519	8	39	,	,	PUNCT
ajbspi-34519	8	40	2024	2024	NUM
ajbspi-34519	8	41	crossref	crossref	PROPN
ajbspi-34519	8	42	doi	doi	PROPN
ajbspi-34519	8	43	:	:	PUNCT
ajbspi-34519	8	44	https://doi.org/10.37547/ajbspi/volume04issue05-04	https://doi.org/10.37547/ajbspi/volume04issue05-04	PROPN
ajbspi-34519	8	45	z.a.sabitova	z.a.sabitova	PROPN
ajbspi-34519	8	46	master	master	NOUN
ajbspi-34519	8	47	's	's	PART
ajbspi-34519	8	48	degree	degree	NOUN
ajbspi-34519	8	49	tashkent	tashkent	PROPN
ajbspi-34519	8	50	international	international	PROPN
ajbspi-34519	8	51	university	university	PROPN
ajbspi-34519	8	52	kimyo	kimyo	NOUN
ajbspi-34519	8	53	,	,	PUNCT
ajbspi-34519	8	54	uzbekistan	uzbekistan	PROPN
ajbspi-34519	8	55	p.a.ganijonov	p.a.ganijonov	NOUN
ajbspi-34519	8	56	assistant	assistant	NOUN
ajbspi-34519	8	57	at	at	ADP
ajbspi-34519	8	58	the	the	DET
ajbspi-34519	8	59	department	department	PROPN
ajbspi-34519	8	60	of	of	ADP
ajbspi-34519	8	61	physiology	physiology	NOUN
ajbspi-34519	8	62	,	,	PUNCT
ajbspi-34519	8	63	fergana	fergana	PROPN
ajbspi-34519	8	64	medical	medical	PROPN
ajbspi-34519	8	65	institute	institute	PROPN
ajbspi-34519	8	66	of	of	ADP
ajbspi-34519	8	67	public	public	PROPN
ajbspi-34519	8	68	health	health	NOUN
ajbspi-34519	8	69	,	,	PUNCT
ajbspi-34519	8	70	uzbekistan	uzbekistan	PROPN
ajbspi-34519	8	71	k.	k.	PROPN
ajbspi-34519	9	1	t.	t.	PROPN
ajbspi-34519	9	2	boboev	boboev	PROPN
ajbspi-34519	9	3	doctor	doctor	NOUN
ajbspi-34519	9	4	of	of	ADP
ajbspi-34519	9	5	medical	medical	ADJ
ajbspi-34519	9	6	sciences	science	NOUN
ajbspi-34519	9	7	.	.	PUNCT
ajbspi-34519	9	8	,	,	PUNCT
ajbspi-34519	9	9	professor	professor	NOUN
ajbspi-34519	9	10	doctor	doctor	NOUN
ajbspi-34519	9	11	of	of	ADP
ajbspi-34519	9	12	medical	medical	ADJ
ajbspi-34519	9	13	sciences	sciences	PROPN
ajbspi-34519	9	14	professor	professor	PROPN
ajbspi-34519	9	15	republican	republican	PROPN
ajbspi-34519	9	16	specialized	specialized	PROPN
ajbspi-34519	9	17	hematology	hematology	NOUN
ajbspi-34519	9	18	scientific	scientific	ADJ
ajbspi-34519	9	19	and	and	CCONJ
ajbspi-34519	9	20	practical	practical	ADJ
ajbspi-34519	9	21	hematology	hematology	NOUN
ajbspi-34519	9	22	and	and	CCONJ
ajbspi-34519	9	23	medical	medical	ADJ
ajbspi-34519	9	24	center	center	NOUN
ajbspi-34519	9	25	,	,	PUNCT
ajbspi-34519	9	26	uzbekistan	uzbekistan	PROPN
ajbspi-34519	9	27	journal	journal	PROPN
ajbspi-34519	9	28	website	website	NOUN
ajbspi-34519	9	29	:	:	PUNCT
ajbspi-34519	9	30	https://theusajournals	https://theusajournals	PROPN
ajbspi-34519	9	31	.	.	PUNCT
ajbspi-34519	9	32	com	com	NOUN
ajbspi-34519	9	33	/	/	SYM
ajbspi-34519	9	34	index.php	index.php	VERB
ajbspi-34519	9	35	/	/	SYM
ajbspi-34519	9	36	ajbspi	ajbspi	NOUN
ajbspi-34519	9	37	copyright	copyright	NOUN
ajbspi-34519	9	38	:	:	PUNCT
ajbspi-34519	9	39	original	original	ADJ
ajbspi-34519	9	40	content	content	NOUN
ajbspi-34519	9	41	from	from	ADP
ajbspi-34519	9	42	this	this	DET
ajbspi-34519	9	43	work	work	NOUN
ajbspi-34519	9	44	may	may	AUX
ajbspi-34519	9	45	be	be	AUX
ajbspi-34519	9	46	used	use	VERB
ajbspi-34519	9	47	under	under	ADP
ajbspi-34519	9	48	the	the	DET
ajbspi-34519	9	49	terms	term	NOUN
ajbspi-34519	9	50	of	of	ADP
ajbspi-34519	9	51	the	the	DET
ajbspi-34519	9	52	creative	creative	ADJ
ajbspi-34519	9	53	commons	common	NOUN
ajbspi-34519	9	54	attributes	attribute	VERB
ajbspi-34519	9	55	4.0	4.0	NUM
ajbspi-34519	9	56	licence	licence	NOUN
ajbspi-34519	9	57	.	.	PUNCT
ajbspi-34519	10	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-34519	10	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	PROPN
ajbspi-34519	11	1	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	PROPN
ajbspi-34519	11	2	https://theusajournals.com/	https://theusajournals.com/	PROPN
ajbspi-34519	11	3	https://doi.org/10.37547/ajbspi/volume04issue05-04	https://doi.org/10.37547/ajbspi/volume04issue05-04	PROPN
ajbspi-34519	11	4	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-34519	11	5	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-34519	11	6	volume	volume	NOUN
ajbspi-34519	11	7	04	04	NUM
ajbspi-34519	11	8	issue	issue	NOUN
ajbspi-34519	11	9	05	05	NUM
ajbspi-34519	11	10	-	-	SYM
ajbspi-34519	11	11	2024	2024	NUM
ajbspi-34519	11	12	20	20	NUM
ajbspi-34519	11	13	american	american	ADJ
ajbspi-34519	11	14	journal	journal	NOUN
ajbspi-34519	11	15	of	of	ADP
ajbspi-34519	11	16	biomedical	biomedical	PROPN
ajbspi-34519	11	17	science	science	PROPN
ajbspi-34519	11	18	&	&	CCONJ
ajbspi-34519	11	19	pharmaceutical	pharmaceutical	PROPN
ajbspi-34519	11	20	innovation	innovation	NOUN
ajbspi-34519	11	21	(	(	PUNCT
ajbspi-34519	11	22	issn	issn	PROPN
ajbspi-34519	11	23	–	–	PUNCT
ajbspi-34519	11	24	2771	2771	NUM
ajbspi-34519	11	25	-	-	SYM
ajbspi-34519	11	26	2753	2753	NUM
ajbspi-34519	11	27	)	)	PUNCT
ajbspi-34519	11	28	volume	volume	NOUN
ajbspi-34519	11	29	04	04	NUM
ajbspi-34519	11	30	issue	issue	NOUN
ajbspi-34519	11	31	05	05	NUM
ajbspi-34519	11	32	pages	page	NOUN
ajbspi-34519	11	33	:	:	PUNCT
ajbspi-34519	11	34	19	19	NUM
ajbspi-34519	11	35	-	-	SYM
ajbspi-34519	11	36	21	21	NUM
ajbspi-34519	11	37	sjif	sjif	NOUN
ajbspi-34519	11	38	impact	impact	NOUN
ajbspi-34519	11	39	factor	factor	NOUN
ajbspi-34519	11	40	(	(	PUNCT
ajbspi-34519	11	41	2022	2022	NUM
ajbspi-34519	11	42	:	:	PUNCT
ajbspi-34519	11	43	5	5	NUM
ajbspi-34519	11	44	.	.	NOUN
ajbspi-34519	11	45	705	705	NUM
ajbspi-34519	11	46	)	)	PUNCT
ajbspi-34519	11	47	(	(	PUNCT
ajbspi-34519	11	48	2023	2023	NUM
ajbspi-34519	11	49	:	:	PUNCT
ajbspi-34519	11	50	6.534	6.534	NUM
ajbspi-34519	11	51	)	)	PUNCT
ajbspi-34519	11	52	(	(	PUNCT
ajbspi-34519	11	53	2024	2024	NUM
ajbspi-34519	11	54	:	:	PUNCT
ajbspi-34519	11	55	7.7	7.7	NUM
ajbspi-34519	11	56	)	)	PUNCT
ajbspi-34519	11	57	oclc	oclc	PROPN
ajbspi-34519	11	58	–	–	PUNCT
ajbspi-34519	11	59	1121105677	1121105677	NUM
ajbspi-34519	11	60	publisher	publisher	NOUN
ajbspi-34519	11	61	:	:	PUNCT
ajbspi-34519	11	62	oscar	oscar	NOUN
ajbspi-34519	11	63	publishing	publishing	NOUN
ajbspi-34519	11	64	services	service	NOUN
ajbspi-34519	11	65	servi	servi	PROPN
ajbspi-34519	11	66	c3435	c3435	PROPN
ajbspi-34519	11	67	t	t	PROPN
ajbspi-34519	11	68	polymorphism	polymorphism	NOUN
ajbspi-34519	11	69	in	in	ADP
ajbspi-34519	11	70	the	the	DET
ajbspi-34519	11	71	mdr1	mdr1	PROPN
ajbspi-34519	11	72	gene	gene	NOUN
ajbspi-34519	11	73	involves	involve	VERB
ajbspi-34519	11	74	a	a	DET
ajbspi-34519	11	75	substitution	substitution	NOUN
ajbspi-34519	11	76	of	of	ADP
ajbspi-34519	11	77	cytosine	cytosine	NOUN
ajbspi-34519	11	78	(	(	PUNCT
ajbspi-34519	11	79	c	c	NOUN
ajbspi-34519	11	80	)	)	PUNCT
ajbspi-34519	11	81	for	for	ADP
ajbspi-34519	11	82	thymine	thymine	PROPN
ajbspi-34519	11	83	(	(	PUNCT
ajbspi-34519	11	84	t	t	PROPN
ajbspi-34519	11	85	)	)	PUNCT
ajbspi-34519	11	86	at	at	ADP
ajbspi-34519	11	87	position	position	NOUN
ajbspi-34519	11	88	3435	3435	NUM
ajbspi-34519	11	89	of	of	ADP
ajbspi-34519	11	90	the	the	DET
ajbspi-34519	11	91	sequence	sequence	NOUN
ajbspi-34519	11	92	and	and	CCONJ
ajbspi-34519	11	93	is	be	AUX
ajbspi-34519	11	94	associated	associate	VERB
ajbspi-34519	11	95	with	with	ADP
ajbspi-34519	11	96	changes	change	NOUN
ajbspi-34519	11	97	in	in	ADP
ajbspi-34519	11	98	p	p	NOUN
ajbspi-34519	11	99	-	-	PUNCT
ajbspi-34519	11	100	gp	gp	NOUN
ajbspi-34519	11	101	expression	expression	NOUN
ajbspi-34519	11	102	and	and	CCONJ
ajbspi-34519	11	103	function	function	NOUN
ajbspi-34519	11	104	,	,	PUNCT
ajbspi-34519	11	105	potentially	potentially	ADV
ajbspi-34519	11	106	affecting	affect	VERB
ajbspi-34519	11	107	its	its	PRON
ajbspi-34519	11	108	ability	ability	NOUN
ajbspi-34519	11	109	to	to	PART
ajbspi-34519	11	110	efficiently	efficiently	ADV
ajbspi-34519	11	111	pump	pump	VERB
ajbspi-34519	11	112	drugs	drug	NOUN
ajbspi-34519	11	113	out	out	ADP
ajbspi-34519	11	114	of	of	ADP
ajbspi-34519	11	115	cells	cell	NOUN
ajbspi-34519	11	116	.	.	PUNCT
ajbspi-34519	12	1	variations	variation	NOUN
ajbspi-34519	12	2	in	in	ADP
ajbspi-34519	12	3	p	p	NOUN
ajbspi-34519	12	4	-	-	PUNCT
ajbspi-34519	12	5	gp	gp	NOUN
ajbspi-34519	12	6	expression	expression	NOUN
ajbspi-34519	12	7	or	or	CCONJ
ajbspi-34519	12	8	function	function	NOUN
ajbspi-34519	12	9	due	due	ADP
ajbspi-34519	12	10	to	to	ADP
ajbspi-34519	12	11	the	the	DET
ajbspi-34519	12	12	c3435	c3435	NOUN
ajbspi-34519	12	13	t	t	NOUN
ajbspi-34519	12	14	polymorphism	polymorphism	NOUN
ajbspi-34519	12	15	could	could	AUX
ajbspi-34519	12	16	potentially	potentially	ADV
ajbspi-34519	12	17	influence	influence	VERB
ajbspi-34519	12	18	the	the	DET
ajbspi-34519	12	19	metabolism	metabolism	NOUN
ajbspi-34519	12	20	of	of	ADP
ajbspi-34519	12	21	endogenous	endogenous	ADJ
ajbspi-34519	12	22	substrates	substrate	NOUN
ajbspi-34519	12	23	or	or	CCONJ
ajbspi-34519	12	24	environmental	environmental	ADJ
ajbspi-34519	12	25	toxins	toxin	NOUN
ajbspi-34519	12	26	,	,	PUNCT
ajbspi-34519	12	27	which	which	PRON
ajbspi-34519	12	28	could	could	AUX
ajbspi-34519	12	29	influence	influence	VERB
ajbspi-34519	12	30	cellular	cellular	ADJ
ajbspi-34519	12	31	processes	process	NOUN
ajbspi-34519	12	32	associated	associate	VERB
ajbspi-34519	12	33	with	with	ADP
ajbspi-34519	12	34	leukemogenesis	leukemogenesis	NOUN
ajbspi-34519	12	35	.	.	PUNCT
ajbspi-34519	13	1	moreover	moreover	ADV
ajbspi-34519	13	2	,	,	PUNCT
ajbspi-34519	13	3	altered	alter	VERB
ajbspi-34519	13	4	p	p	NOUN
ajbspi-34519	13	5	-	-	PUNCT
ajbspi-34519	13	6	gp	gp	NOUN
ajbspi-34519	13	7	expression	expression	NOUN
ajbspi-34519	13	8	or	or	CCONJ
ajbspi-34519	13	9	function	function	NOUN
ajbspi-34519	13	10	due	due	ADP
ajbspi-34519	13	11	to	to	ADP
ajbspi-34519	13	12	the	the	DET
ajbspi-34519	13	13	c3435	c3435	NOUN
ajbspi-34519	13	14	t	t	NOUN
ajbspi-34519	13	15	polymorphism	polymorphism	NOUN
ajbspi-34519	13	16	may	may	AUX
ajbspi-34519	13	17	disrupt	disrupt	VERB
ajbspi-34519	13	18	cellular	cellular	ADJ
ajbspi-34519	13	19	homeostasis	homeostasis	NOUN
ajbspi-34519	13	20	,	,	PUNCT
ajbspi-34519	13	21	potentially	potentially	ADV
ajbspi-34519	13	22	leading	lead	VERB
ajbspi-34519	13	23	to	to	ADP
ajbspi-34519	13	24	increased	increase	VERB
ajbspi-34519	13	25	genomic	genomic	ADJ
ajbspi-34519	13	26	instability	instability	NOUN
ajbspi-34519	13	27	or	or	CCONJ
ajbspi-34519	13	28	disruption	disruption	NOUN
ajbspi-34519	13	29	of	of	ADP
ajbspi-34519	13	30	dna	dna	PROPN
ajbspi-34519	13	31	repair	repair	NOUN
ajbspi-34519	13	32	mechanisms	mechanism	NOUN
ajbspi-34519	13	33	,	,	PUNCT
ajbspi-34519	13	34	which	which	PRON
ajbspi-34519	13	35	are	be	AUX
ajbspi-34519	13	36	known	know	VERB
ajbspi-34519	13	37	to	to	PART
ajbspi-34519	13	38	contribute	contribute	VERB
ajbspi-34519	13	39	to	to	ADP
ajbspi-34519	13	40	the	the	DET
ajbspi-34519	13	41	development	development	NOUN
ajbspi-34519	13	42	of	of	ADP
ajbspi-34519	13	43	leukemia	leukemia	NOUN
ajbspi-34519	13	44	[	[	X
ajbspi-34519	13	45	1,2,3,4	1,2,3,4	NUM
ajbspi-34519	13	46	,	,	PUNCT
ajbspi-34519	13	47	5	5	NUM
ajbspi-34519	13	48	]	]	PUNCT
ajbspi-34519	13	49	.	.	PUNCT
ajbspi-34519	14	1	purpose	purpose	NOUN
ajbspi-34519	14	2	of	of	ADP
ajbspi-34519	14	3	the	the	DET
ajbspi-34519	14	4	study	study	NOUN
ajbspi-34519	14	5	to	to	PART
ajbspi-34519	14	6	develop	develop	VERB
ajbspi-34519	14	7	a	a	DET
ajbspi-34519	14	8	pcr	pcr	ADJ
ajbspi-34519	14	9	method	method	NOUN
ajbspi-34519	14	10	to	to	PART
ajbspi-34519	14	11	detect	detect	VERB
ajbspi-34519	14	12	the	the	DET
ajbspi-34519	14	13	c3435	c3435	PROPN
ajbspi-34519	14	14	t	t	NOUN
ajbspi-34519	14	15	polymorphism	polymorphism	NOUN
ajbspi-34519	14	16	of	of	ADP
ajbspi-34519	14	17	the	the	DET
ajbspi-34519	14	18	mdr1	mdr1	PROPN
ajbspi-34519	14	19	gene	gene	NOUN
ajbspi-34519	14	20	and	and	CCONJ
ajbspi-34519	14	21	evaluate	evaluate	VERB
ajbspi-34519	14	22	its	its	PRON
ajbspi-34519	14	23	role	role	NOUN
ajbspi-34519	14	24	in	in	ADP
ajbspi-34519	14	25	the	the	DET
ajbspi-34519	14	26	formation	formation	NOUN
ajbspi-34519	14	27	of	of	ADP
ajbspi-34519	14	28	acute	acute	ADJ
ajbspi-34519	14	29	and	and	CCONJ
ajbspi-34519	14	30	chronic	chronic	ADJ
ajbspi-34519	14	31	leukemia	leukemia	NOUN
ajbspi-34519	14	32	.	.	PUNCT
ajbspi-34519	15	1	materials	material	NOUN
ajbspi-34519	15	2	and	and	CCONJ
ajbspi-34519	15	3	methods	method	NOUN
ajbspi-34519	15	4	of	of	ADP
ajbspi-34519	15	5	research	research	NOUN
ajbspi-34519	15	6	the	the	DET
ajbspi-34519	15	7	study	study	NOUN
ajbspi-34519	15	8	included	include	VERB
ajbspi-34519	15	9	103	103	NUM
ajbspi-34519	15	10	patients	patient	NOUN
ajbspi-34519	15	11	suffering	suffer	VERB
ajbspi-34519	15	12	from	from	ADP
ajbspi-34519	15	13	acute	acute	ADJ
ajbspi-34519	15	14	leukemia	leukemia	NOUN
ajbspi-34519	15	15	,	,	PUNCT
ajbspi-34519	15	16	who	who	PRON
ajbspi-34519	15	17	were	be	AUX
ajbspi-34519	15	18	registered	register	VERB
ajbspi-34519	15	19	at	at	ADP
ajbspi-34519	15	20	the	the	DET
ajbspi-34519	15	21	republican	republican	ADJ
ajbspi-34519	15	22	specialized	specialized	ADJ
ajbspi-34519	15	23	scientific	scientific	ADJ
ajbspi-34519	15	24	and	and	CCONJ
ajbspi-34519	15	25	practical	practical	ADJ
ajbspi-34519	15	26	medical	medical	ADJ
ajbspi-34519	15	27	center	center	NOUN
ajbspi-34519	15	28	for	for	ADP
ajbspi-34519	15	29	hematology	hematology	NOUN
ajbspi-34519	15	30	of	of	ADP
ajbspi-34519	15	31	the	the	DET
ajbspi-34519	15	32	ministry	ministry	PROPN
ajbspi-34519	15	33	of	of	ADP
ajbspi-34519	15	34	health	health	PROPN
ajbspi-34519	15	35	of	of	ADP
ajbspi-34519	15	36	the	the	DET
ajbspi-34519	15	37	republic	republic	NOUN
ajbspi-34519	15	38	of	of	ADP
ajbspi-34519	15	39	uzbekistan	uzbekistan	PROPN
ajbspi-34519	15	40	,	,	PUNCT
ajbspi-34519	15	41	and	and	CCONJ
ajbspi-34519	15	42	90	90	NUM
ajbspi-34519	15	43	conditionally	conditionally	ADV
ajbspi-34519	15	44	healthy	healthy	ADJ
ajbspi-34519	15	45	individuals	individual	NOUN
ajbspi-34519	15	46	were	be	AUX
ajbspi-34519	15	47	selected	select	VERB
ajbspi-34519	15	48	as	as	ADP
ajbspi-34519	15	49	a	a	DET
ajbspi-34519	15	50	control	control	NOUN
ajbspi-34519	15	51	group	group	NOUN
ajbspi-34519	15	52	,	,	PUNCT
ajbspi-34519	15	53	of	of	ADP
ajbspi-34519	15	54	which	which	PRON
ajbspi-34519	15	55	50	50	NUM
ajbspi-34519	15	56	people	people	NOUN
ajbspi-34519	15	57	did	do	AUX
ajbspi-34519	15	58	not	not	PART
ajbspi-34519	15	59	have	have	VERB
ajbspi-34519	15	60	oncohematological	oncohematological	ADJ
ajbspi-34519	15	61	diseases	disease	NOUN
ajbspi-34519	15	62	or	or	CCONJ
ajbspi-34519	15	63	history	history	NOUN
ajbspi-34519	15	64	of	of	ADP
ajbspi-34519	15	65	thrombosis	thrombosis	NOUN
ajbspi-34519	15	66	.	.	PUNCT
ajbspi-34519	16	1	results	result	VERB
ajbspi-34519	16	2	carriers	carrier	NOUN
ajbspi-34519	16	3	of	of	ADP
ajbspi-34519	16	4	the	the	DET
ajbspi-34519	16	5	c	c	PROPN
ajbspi-34519	16	6	allele	allele	PROPN
ajbspi-34519	16	7	showed	show	VERB
ajbspi-34519	16	8	a	a	DET
ajbspi-34519	16	9	significant	significant	ADJ
ajbspi-34519	16	10	decrease	decrease	NOUN
ajbspi-34519	16	11	in	in	ADP
ajbspi-34519	16	12	the	the	DET
ajbspi-34519	16	13	likelihood	likelihood	NOUN
ajbspi-34519	16	14	of	of	ADP
ajbspi-34519	16	15	developing	develop	VERB
ajbspi-34519	16	16	the	the	DET
ajbspi-34519	16	17	disease	disease	NOUN
ajbspi-34519	16	18	by	by	ADP
ajbspi-34519	16	19	41	41	NUM
ajbspi-34519	16	20	%	%	NOUN
ajbspi-34519	16	21	(	(	PUNCT
ajbspi-34519	16	22	or	or	CCONJ
ajbspi-34519	16	23	=	=	SYM
ajbspi-34519	16	24	0.59	0.59	NUM
ajbspi-34519	16	25	,	,	PUNCT
ajbspi-34519	16	26	95	95	NUM
ajbspi-34519	16	27	%	%	NOUN
ajbspi-34519	16	28	ci	ci	NOUN
ajbspi-34519	16	29	:	:	PUNCT
ajbspi-34519	16	30	0.39	0.39	NUM
ajbspi-34519	16	31	-	-	SYM
ajbspi-34519	16	32	0.89	0.89	NUM
ajbspi-34519	16	33	;	;	PUNCT
ajbspi-34519	16	34	p	p	X
ajbspi-34519	16	35	=	=	NOUN
ajbspi-34519	16	36	0.01	0.01	NUM
ajbspi-34519	16	37	)	)	PUNCT
ajbspi-34519	16	38	,	,	PUNCT
ajbspi-34519	16	39	while	while	SCONJ
ajbspi-34519	16	40	the	the	DET
ajbspi-34519	16	41	minor	minor	ADJ
ajbspi-34519	16	42	t	t	NOUN
ajbspi-34519	16	43	allele	allele	NOUN
ajbspi-34519	16	44	of	of	ADP
ajbspi-34519	16	45	the	the	DET
ajbspi-34519	16	46	mdr1	mdr1	PROPN
ajbspi-34519	16	47	c3435	c3435	PROPN
ajbspi-34519	16	48	t	t	PROPN
ajbspi-34519	16	49	gene	gene	NOUN
ajbspi-34519	16	50	significantly	significantly	ADV
ajbspi-34519	16	51	increased	increase	VERB
ajbspi-34519	16	52	the	the	DET
ajbspi-34519	16	53	risk	risk	NOUN
ajbspi-34519	16	54	1.69	1.69	NUM
ajbspi-34519	16	55	times	time	NOUN
ajbspi-34519	16	56	(	(	PUNCT
ajbspi-34519	16	57	or	or	CCONJ
ajbspi-34519	16	58	=	=	SYM
ajbspi-34519	16	59	1.69	1.69	NUM
ajbspi-34519	16	60	;	;	PUNCT
ajbspi-34519	16	61	95	95	NUM
ajbspi-34519	16	62	%	%	NOUN
ajbspi-34519	16	63	ci	ci	NOUN
ajbspi-34519	16	64	:	:	PUNCT
ajbspi-34519	16	65	1.13	1.13	NUM
ajbspi-34519	16	66	-	-	SYM
ajbspi-34519	16	67	2.55	2.55	NUM
ajbspi-34519	16	68	;	;	PUNCT
ajbspi-34519	16	69	p	p	X
ajbspi-34519	16	70	=	=	NOUN
ajbspi-34519	16	71	0.01	0.01	NUM
ajbspi-34519	16	72	)	)	PUNCT
ajbspi-34519	16	73	.	.	PUNCT
ajbspi-34519	17	1	analysis	analysis	NOUN
ajbspi-34519	17	2	of	of	ADP
ajbspi-34519	17	3	the	the	DET
ajbspi-34519	17	4	c3435	c3435	NOUN
ajbspi-34519	17	5	t	t	NOUN
ajbspi-34519	17	6	polymorphism	polymorphism	NOUN
ajbspi-34519	17	7	showed	show	VERB
ajbspi-34519	17	8	that	that	SCONJ
ajbspi-34519	17	9	the	the	DET
ajbspi-34519	17	10	tt	tt	PROPN
ajbspi-34519	17	11	genotype	genotype	NOUN
ajbspi-34519	17	12	increases	increase	VERB
ajbspi-34519	17	13	the	the	DET
ajbspi-34519	17	14	risk	risk	NOUN
ajbspi-34519	17	15	of	of	ADP
ajbspi-34519	17	16	the	the	DET
ajbspi-34519	17	17	disease	disease	NOUN
ajbspi-34519	17	18	by	by	ADP
ajbspi-34519	17	19	2.31	2.31	NUM
ajbspi-34519	17	20	times	time	NOUN
ajbspi-34519	17	21	(	(	PUNCT
ajbspi-34519	17	22	or	or	CCONJ
ajbspi-34519	17	23	=	=	SYM
ajbspi-34519	17	24	2.31	2.31	NUM
ajbspi-34519	17	25	;	;	PUNCT
ajbspi-34519	17	26	95	95	NUM
ajbspi-34519	17	27	%	%	NOUN
ajbspi-34519	17	28	ci	ci	NOUN
ajbspi-34519	17	29	:	:	PUNCT
ajbspi-34519	17	30	1.09	1.09	NUM
ajbspi-34519	17	31	-	-	SYM
ajbspi-34519	17	32	4.89	4.89	NUM
ajbspi-34519	17	33	;	;	PUNCT
ajbspi-34519	17	34	p	p	X
ajbspi-34519	17	35	=	=	PROPN
ajbspi-34519	17	36	0.027	0.027	NUM
ajbspi-34519	17	37	)	)	PUNCT
ajbspi-34519	17	38	,	,	PUNCT
ajbspi-34519	17	39	while	while	SCONJ
ajbspi-34519	17	40	the	the	DET
ajbspi-34519	17	41	cc	cc	PROPN
ajbspi-34519	17	42	genotype	genotype	NOUN
ajbspi-34519	17	43	demonstrates	demonstrate	VERB
ajbspi-34519	17	44	a	a	DET
ajbspi-34519	17	45	44	44	NUM
ajbspi-34519	17	46	%	%	NOUN
ajbspi-34519	17	47	reduction	reduction	NOUN
ajbspi-34519	17	48	in	in	ADP
ajbspi-34519	17	49	risk	risk	NOUN
ajbspi-34519	17	50	(	(	PUNCT
ajbspi-34519	17	51	or	or	CCONJ
ajbspi-34519	17	52	=	=	SYM
ajbspi-34519	17	53	0.56	0.56	NUM
ajbspi-34519	17	54	,	,	PUNCT
ajbspi-34519	17	55	95	95	NUM
ajbspi-34519	17	56	%	%	NOUN
ajbspi-34519	17	57	ci	ci	NOUN
ajbspi-34519	17	58	:	:	PUNCT
ajbspi-34519	17	59	0.31	0.31	NUM
ajbspi-34519	17	60	-	-	SYM
ajbspi-34519	17	61	1.03	1.03	NUM
ajbspi-34519	17	62	,	,	PUNCT
ajbspi-34519	17	63	p	p	NOUN
ajbspi-34519	17	64	=	=	NOUN
ajbspi-34519	17	65	0.06	0.06	NUM
ajbspi-34519	17	66	)	)	PUNCT
ajbspi-34519	17	67	.	.	PUNCT
ajbspi-34519	18	1	it	it	PRON
ajbspi-34519	18	2	is	be	AUX
ajbspi-34519	18	3	noteworthy	noteworthy	ADJ
ajbspi-34519	18	4	that	that	SCONJ
ajbspi-34519	18	5	in	in	ADP
ajbspi-34519	18	6	this	this	DET
ajbspi-34519	18	7	study	study	NOUN
ajbspi-34519	18	8	,	,	PUNCT
ajbspi-34519	18	9	the	the	DET
ajbspi-34519	18	10	tt	tt	PROPN
ajbspi-34519	18	11	genotype	genotype	NOUN
ajbspi-34519	18	12	was	be	AUX
ajbspi-34519	18	13	found	find	VERB
ajbspi-34519	18	14	to	to	PART
ajbspi-34519	18	15	be	be	AUX
ajbspi-34519	18	16	a	a	DET
ajbspi-34519	18	17	significant	significant	ADJ
ajbspi-34519	18	18	risk	risk	NOUN
ajbspi-34519	18	19	factor	factor	NOUN
ajbspi-34519	18	20	for	for	ADP
ajbspi-34519	18	21	the	the	DET
ajbspi-34519	18	22	development	development	NOUN
ajbspi-34519	18	23	of	of	ADP
ajbspi-34519	18	24	the	the	DET
ajbspi-34519	18	25	disease	disease	NOUN
ajbspi-34519	18	26	.	.	PUNCT
ajbspi-34519	19	1	in	in	ADP
ajbspi-34519	19	2	our	our	PRON
ajbspi-34519	19	3	study	study	NOUN
ajbspi-34519	19	4	,	,	PUNCT
ajbspi-34519	19	5	the	the	DET
ajbspi-34519	19	6	main	main	ADJ
ajbspi-34519	19	7	group	group	NOUN
ajbspi-34519	19	8	of	of	ADP
ajbspi-34519	19	9	patients	patient	NOUN
ajbspi-34519	19	10	(	(	PUNCT
ajbspi-34519	19	11	n=103	n=103	NOUN
ajbspi-34519	19	12	)	)	PUNCT
ajbspi-34519	19	13	was	be	AUX
ajbspi-34519	19	14	divided	divide	VERB
ajbspi-34519	19	15	into	into	ADP
ajbspi-34519	19	16	subgroups	subgroup	NOUN
ajbspi-34519	19	17	depending	depend	VERB
ajbspi-34519	19	18	on	on	ADP
ajbspi-34519	19	19	the	the	DET
ajbspi-34519	19	20	acute	acute	NOUN
ajbspi-34519	19	21	(	(	PUNCT
ajbspi-34519	19	22	first	first	ADJ
ajbspi-34519	19	23	subgroup	subgroup	NOUN
ajbspi-34519	19	24	)	)	PUNCT
ajbspi-34519	19	25	or	or	CCONJ
ajbspi-34519	19	26	chronic	chronic	ADJ
ajbspi-34519	19	27	(	(	PUNCT
ajbspi-34519	19	28	second	second	ADJ
ajbspi-34519	19	29	subgroup	subgroup	NOUN
ajbspi-34519	19	30	)	)	PUNCT
ajbspi-34519	19	31	course	course	NOUN
ajbspi-34519	19	32	of	of	ADP
ajbspi-34519	19	33	leukemia	leukemia	NOUN
ajbspi-34519	19	34	.	.	PUNCT
ajbspi-34519	20	1	regarding	regard	VERB
ajbspi-34519	20	2	the	the	DET
ajbspi-34519	20	3	pathogenetic	pathogenetic	ADJ
ajbspi-34519	20	4	significance	significance	NOUN
ajbspi-34519	20	5	of	of	ADP
ajbspi-34519	20	6	the	the	DET
ajbspi-34519	20	7	c3435	c3435	PROPN
ajbspi-34519	20	8	t	t	NOUN
ajbspi-34519	20	9	polymorphism	polymorphism	NOUN
ajbspi-34519	20	10	of	of	ADP
ajbspi-34519	20	11	the	the	DET
ajbspi-34519	20	12	mdr1	mdr1	PROPN
ajbspi-34519	20	13	gene	gene	NOUN
ajbspi-34519	20	14	in	in	ADP
ajbspi-34519	20	15	the	the	DET
ajbspi-34519	20	16	first	first	ADJ
ajbspi-34519	20	17	subgroup	subgroup	NOUN
ajbspi-34519	20	18	,	,	PUNCT
ajbspi-34519	20	19	carriers	carrier	NOUN
ajbspi-34519	20	20	of	of	ADP
ajbspi-34519	20	21	the	the	DET
ajbspi-34519	20	22	c	c	PROPN
ajbspi-34519	20	23	allele	allele	PROPN
ajbspi-34519	20	24	had	have	VERB
ajbspi-34519	20	25	a	a	DET
ajbspi-34519	20	26	noticeable	noticeable	ADJ
ajbspi-34519	20	27	reduction	reduction	NOUN
ajbspi-34519	20	28	in	in	ADP
ajbspi-34519	20	29	the	the	DET
ajbspi-34519	20	30	likelihood	likelihood	NOUN
ajbspi-34519	20	31	of	of	ADP
ajbspi-34519	20	32	developing	develop	VERB
ajbspi-34519	20	33	the	the	DET
ajbspi-34519	20	34	disease	disease	NOUN
ajbspi-34519	20	35	by	by	ADP
ajbspi-34519	20	36	48	48	NUM
ajbspi-34519	20	37	%	%	NOUN
ajbspi-34519	20	38	(	(	PUNCT
ajbspi-34519	20	39	or	or	CCONJ
ajbspi-34519	20	40	=	=	SYM
ajbspi-34519	20	41	0.52	0.52	NUM
ajbspi-34519	20	42	,	,	PUNCT
ajbspi-34519	20	43	95	95	NUM
ajbspi-34519	20	44	%	%	NOUN
ajbspi-34519	20	45	ci	ci	NOUN
ajbspi-34519	20	46	:	:	PUNCT
ajbspi-34519	20	47	0.32	0.32	NUM
ajbspi-34519	20	48	-	-	SYM
ajbspi-34519	20	49	0.84	0.84	NUM
ajbspi-34519	20	50	;	;	PUNCT
ajbspi-34519	20	51	p	p	X
ajbspi-34519	20	52	=	=	NOUN
ajbspi-34519	20	53	0.008	0.008	NUM
ajbspi-34519	20	54	)	)	PUNCT
ajbspi-34519	20	55	.	.	PUNCT
ajbspi-34519	21	1	conversely	conversely	ADV
ajbspi-34519	21	2	,	,	PUNCT
ajbspi-34519	21	3	the	the	DET
ajbspi-34519	21	4	minor	minor	ADJ
ajbspi-34519	21	5	t	t	NOUN
ajbspi-34519	21	6	allele	allele	NOUN
ajbspi-34519	21	7	of	of	ADP
ajbspi-34519	21	8	the	the	DET
ajbspi-34519	21	9	mdr1	mdr1	PROPN
ajbspi-34519	21	10	c3435	c3435	PROPN
ajbspi-34519	21	11	t	t	PROPN
ajbspi-34519	21	12	polymorphism	polymorphism	NOUN
ajbspi-34519	21	13	significantly	significantly	ADV
ajbspi-34519	21	14	increased	increase	VERB
ajbspi-34519	21	15	the	the	DET
ajbspi-34519	21	16	risk	risk	NOUN
ajbspi-34519	21	17	of	of	ADP
ajbspi-34519	21	18	the	the	DET
ajbspi-34519	21	19	disease	disease	NOUN
ajbspi-34519	21	20	by	by	ADP
ajbspi-34519	21	21	1.93	1.93	NUM
ajbspi-34519	21	22	times	time	NOUN
ajbspi-34519	21	23	(	(	PUNCT
ajbspi-34519	21	24	or	or	CCONJ
ajbspi-34519	21	25	=	=	SYM
ajbspi-34519	21	26	1.93	1.93	NUM
ajbspi-34519	21	27	;	;	PUNCT
ajbspi-34519	21	28	95	95	NUM
ajbspi-34519	21	29	%	%	NOUN
ajbspi-34519	21	30	ci	ci	NOUN
ajbspi-34519	21	31	:	:	PUNCT
ajbspi-34519	21	32	1.19	1.19	NUM
ajbspi-34519	21	33	-	-	SYM
ajbspi-34519	21	34	3.15	3.15	NUM
ajbspi-34519	21	35	;	;	PUNCT
ajbspi-34519	21	36	p	p	X
ajbspi-34519	21	37	=	=	NOUN
ajbspi-34519	21	38	0.008	0.008	NUM
ajbspi-34519	21	39	)	)	PUNCT
ajbspi-34519	21	40	,	,	PUNCT
ajbspi-34519	21	41	becoming	become	VERB
ajbspi-34519	21	42	a	a	DET
ajbspi-34519	21	43	significant	significant	ADJ
ajbspi-34519	21	44	risk	risk	NOUN
ajbspi-34519	21	45	factor	factor	NOUN
ajbspi-34519	21	46	for	for	ADP
ajbspi-34519	21	47	the	the	DET
ajbspi-34519	21	48	development	development	NOUN
ajbspi-34519	21	49	of	of	ADP
ajbspi-34519	21	50	acute	acute	ADJ
ajbspi-34519	21	51	leukemia	leukemia	NOUN
ajbspi-34519	21	52	in	in	ADP
ajbspi-34519	21	53	our	our	PRON
ajbspi-34519	21	54	research	research	NOUN
ajbspi-34519	21	55	.	.	PUNCT
ajbspi-34519	22	1	on	on	ADP
ajbspi-34519	22	2	the	the	DET
ajbspi-34519	22	3	other	other	ADJ
ajbspi-34519	22	4	hand	hand	NOUN
ajbspi-34519	22	5	,	,	PUNCT
ajbspi-34519	22	6	our	our	PRON
ajbspi-34519	22	7	study	study	NOUN
ajbspi-34519	22	8	did	do	AUX
ajbspi-34519	22	9	not	not	PART
ajbspi-34519	22	10	reveal	reveal	VERB
ajbspi-34519	22	11	a	a	DET
ajbspi-34519	22	12	statistically	statistically	ADV
ajbspi-34519	22	13	significant	significant	ADJ
ajbspi-34519	22	14	relationship	relationship	NOUN
ajbspi-34519	22	15	between	between	ADP
ajbspi-34519	22	16	the	the	DET
ajbspi-34519	22	17	second	second	ADJ
ajbspi-34519	22	18	group	group	NOUN
ajbspi-34519	22	19	(	(	PUNCT
ajbspi-34519	22	20	chronic	chronic	ADJ
ajbspi-34519	22	21	leukemia	leukemia	NOUN
ajbspi-34519	22	22	)	)	PUNCT
ajbspi-34519	22	23	and	and	CCONJ
ajbspi-34519	22	24	the	the	DET
ajbspi-34519	22	25	c3435	c3435	PROPN
ajbspi-34519	22	26	t	t	PROPN
ajbspi-34519	22	27	polymorphism	polymorphism	NOUN
ajbspi-34519	22	28	of	of	ADP
ajbspi-34519	22	29	the	the	DET
ajbspi-34519	22	30	mdr1	mdr1	PROPN
ajbspi-34519	22	31	gene	gene	NOUN
ajbspi-34519	22	32	(	(	PUNCT
ajbspi-34519	22	33	χ2<3.85	χ2<3.85	ADJ
ajbspi-34519	22	34	;	;	PUNCT
ajbspi-34519	22	35	p>0.05	p>0.05	PROPN
ajbspi-34519	22	36	)	)	PUNCT
ajbspi-34519	22	37	.	.	PUNCT
ajbspi-34519	23	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-34519	23	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-34519	23	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-34519	23	4	volume	volume	NOUN
ajbspi-34519	23	5	04	04	NUM
ajbspi-34519	23	6	issue	issue	NOUN
ajbspi-34519	23	7	05	05	NUM
ajbspi-34519	23	8	-	-	SYM
ajbspi-34519	23	9	2024	2024	NUM
ajbspi-34519	23	10	21	21	NUM
ajbspi-34519	23	11	american	american	ADJ
ajbspi-34519	23	12	journal	journal	NOUN
ajbspi-34519	23	13	of	of	ADP
ajbspi-34519	23	14	biomedical	biomedical	PROPN
ajbspi-34519	23	15	science	science	PROPN
ajbspi-34519	23	16	&	&	CCONJ
ajbspi-34519	23	17	pharmaceutical	pharmaceutical	PROPN
ajbspi-34519	23	18	innovation	innovation	NOUN
ajbspi-34519	23	19	(	(	PUNCT
ajbspi-34519	23	20	issn	issn	PROPN
ajbspi-34519	23	21	–	–	PUNCT
ajbspi-34519	23	22	2771	2771	NUM
ajbspi-34519	23	23	-	-	SYM
ajbspi-34519	23	24	2753	2753	NUM
ajbspi-34519	23	25	)	)	PUNCT
ajbspi-34519	23	26	volume	volume	NOUN
ajbspi-34519	23	27	04	04	NUM
ajbspi-34519	23	28	issue	issue	NOUN
ajbspi-34519	23	29	05	05	NUM
ajbspi-34519	23	30	pages	page	NOUN
ajbspi-34519	23	31	:	:	PUNCT
ajbspi-34519	23	32	19	19	NUM
ajbspi-34519	23	33	-	-	SYM
ajbspi-34519	23	34	21	21	NUM
ajbspi-34519	23	35	sjif	sjif	NOUN
ajbspi-34519	23	36	impact	impact	NOUN
ajbspi-34519	23	37	factor	factor	NOUN
ajbspi-34519	23	38	(	(	PUNCT
ajbspi-34519	23	39	2022	2022	NUM
ajbspi-34519	23	40	:	:	PUNCT
ajbspi-34519	23	41	5	5	NUM
ajbspi-34519	23	42	.	.	NOUN
ajbspi-34519	23	43	705	705	NUM
ajbspi-34519	23	44	)	)	PUNCT
ajbspi-34519	23	45	(	(	PUNCT
ajbspi-34519	23	46	2023	2023	NUM
ajbspi-34519	23	47	:	:	PUNCT
ajbspi-34519	23	48	6.534	6.534	NUM
ajbspi-34519	23	49	)	)	PUNCT
ajbspi-34519	23	50	(	(	PUNCT
ajbspi-34519	23	51	2024	2024	NUM
ajbspi-34519	23	52	:	:	PUNCT
ajbspi-34519	23	53	7.7	7.7	NUM
ajbspi-34519	23	54	)	)	PUNCT
ajbspi-34519	23	55	oclc	oclc	PROPN
ajbspi-34519	23	56	–	–	PUNCT
ajbspi-34519	23	57	1121105677	1121105677	NUM
ajbspi-34519	23	58	publisher	publisher	NOUN
ajbspi-34519	23	59	:	:	PUNCT
ajbspi-34519	23	60	oscar	oscar	NOUN
ajbspi-34519	23	61	publishing	publishing	NOUN
ajbspi-34519	23	62	services	service	NOUN
ajbspi-34519	23	63	servi	servi	ADJ
ajbspi-34519	23	64	conclusion	conclusion	NOUN
ajbspi-34519	23	65	in	in	ADP
ajbspi-34519	23	66	our	our	PRON
ajbspi-34519	23	67	study	study	NOUN
ajbspi-34519	23	68	,	,	PUNCT
ajbspi-34519	23	69	the	the	DET
ajbspi-34519	23	70	minor	minor	ADJ
ajbspi-34519	23	71	allele	allele	NOUN
ajbspi-34519	23	72	(	(	PUNCT
ajbspi-34519	23	73	t	t	NOUN
ajbspi-34519	23	74	)	)	PUNCT
ajbspi-34519	23	75	of	of	ADP
ajbspi-34519	23	76	the	the	DET
ajbspi-34519	23	77	c3435	c3435	PROPN
ajbspi-34519	23	78	t	t	NOUN
ajbspi-34519	23	79	polymorphism	polymorphism	NOUN
ajbspi-34519	23	80	of	of	ADP
ajbspi-34519	23	81	the	the	DET
ajbspi-34519	23	82	mdr1	mdr1	PROPN
ajbspi-34519	23	83	gene	gene	NOUN
ajbspi-34519	23	84	demonstrated	demonstrate	VERB
ajbspi-34519	23	85	a	a	DET
ajbspi-34519	23	86	significant	significant	ADJ
ajbspi-34519	23	87	positive	positive	ADJ
ajbspi-34519	23	88	association	association	NOUN
ajbspi-34519	23	89	with	with	ADP
ajbspi-34519	23	90	acute	acute	ADJ
ajbspi-34519	23	91	leukemia	leukemia	NOUN
ajbspi-34519	23	92	(	(	PUNCT
ajbspi-34519	23	93	or=1.93	or=1.93	NOUN
ajbspi-34519	23	94	;	;	PUNCT
ajbspi-34519	23	95	95	95	NUM
ajbspi-34519	23	96	%	%	NOUN
ajbspi-34519	23	97	ci	ci	NOUN
ajbspi-34519	23	98	:	:	PUNCT
ajbspi-34519	23	99	1.19	1.19	NUM
ajbspi-34519	23	100	-	-	SYM
ajbspi-34519	23	101	3.15	3.15	NUM
ajbspi-34519	23	102	,	,	PUNCT
ajbspi-34519	23	103	χ2=7.13	χ2=7.13	NUM
ajbspi-34519	23	104	;	;	PUNCT
ajbspi-34519	23	105	p=0.008	p=0.008	NOUN
ajbspi-34519	23	106	)	)	PUNCT
ajbspi-34519	23	107	.	.	PUNCT
ajbspi-34519	24	1	on	on	ADP
ajbspi-34519	24	2	the	the	DET
ajbspi-34519	24	3	contrary	contrary	NOUN
ajbspi-34519	24	4	,	,	PUNCT
ajbspi-34519	24	5	no	no	DET
ajbspi-34519	24	6	statistically	statistically	ADV
ajbspi-34519	24	7	significant	significant	ADJ
ajbspi-34519	24	8	relationship	relationship	NOUN
ajbspi-34519	24	9	was	be	AUX
ajbspi-34519	24	10	observed	observe	VERB
ajbspi-34519	24	11	between	between	ADP
ajbspi-34519	24	12	the	the	DET
ajbspi-34519	24	13	second	second	ADJ
ajbspi-34519	24	14	group	group	NOUN
ajbspi-34519	24	15	(	(	PUNCT
ajbspi-34519	24	16	chronic	chronic	ADJ
ajbspi-34519	24	17	leukemia	leukemia	NOUN
ajbspi-34519	24	18	)	)	PUNCT
ajbspi-34519	24	19	and	and	CCONJ
ajbspi-34519	24	20	the	the	DET
ajbspi-34519	24	21	c3435	c3435	PROPN
ajbspi-34519	24	22	t	t	PROPN
ajbspi-34519	24	23	polymorphism	polymorphism	NOUN
ajbspi-34519	24	24	of	of	ADP
ajbspi-34519	24	25	the	the	DET
ajbspi-34519	24	26	mdr1	mdr1	PROPN
ajbspi-34519	24	27	gene	gene	NOUN
ajbspi-34519	24	28	(	(	PUNCT
ajbspi-34519	24	29	χ2<3.85	χ2<3.85	ADJ
ajbspi-34519	24	30	;	;	PUNCT
ajbspi-34519	24	31	p>0.05	p>0.05	PROPN
ajbspi-34519	24	32	)	)	PUNCT
ajbspi-34519	24	33	.	.	PUNCT
ajbspi-34519	25	1	references	reference	NOUN
ajbspi-34519	25	2	1	1	X
ajbspi-34519	25	3	.	.	PUNCT
ajbspi-34519	26	1	коркина	коркина	PROPN
ajbspi-34519	26	2	ю	ю	PROPN
ajbspi-34519	26	3	.	.	PUNCT
ajbspi-34519	27	1	с	с	PROPN
ajbspi-34519	27	2	.	.	PROPN
ajbspi-34519	27	3	,	,	PUNCT
ajbspi-34519	27	4	валиев	валиев	VERB
ajbspi-34519	27	5	т	т	PROPN
ajbspi-34519	27	6	.	.	PUNCT
ajbspi-34519	27	7	т	т	X
ajbspi-34519	27	8	.	.	PROPN
ajbspi-34519	27	9	,	,	PUNCT
ajbspi-34519	27	10	варфоломеева	варфоломеева	PROPN
ajbspi-34519	27	11	с	с	PROPN
ajbspi-34519	27	12	.	.	PUNCT
ajbspi-34519	28	1	р	р	PROPN
ajbspi-34519	28	2	.	.	PROPN
ajbspi-34519	29	1	клинические	клинические	PROPN
ajbspi-34519	29	2	и	и	PROPN
ajbspi-34519	29	3	молекулярно	молекулярно	PROPN
ajbspi-34519	29	4	-	-	PUNCT
ajbspi-34519	29	5	биологические	биологические	VERB
ajbspi-34519	29	6	особенности	особенности	NOUN
ajbspi-34519	29	7	острых	острых	NOUN
ajbspi-34519	29	8	лейкозов	лейкозов	VERB
ajbspi-34519	29	9	у	у	PROPN
ajbspi-34519	29	10	детей	детей	NOUN
ajbspi-34519	29	11	до	до	PRON
ajbspi-34519	29	12	1	1	NUM
ajbspi-34519	29	13	года	года	ADJ
ajbspi-34519	29	14	//онкогематология	//онкогематология	PUNCT
ajbspi-34519	29	15	.	.	PUNCT
ajbspi-34519	30	1	–	–	PUNCT
ajbspi-34519	30	2	2022	2022	NUM
ajbspi-34519	30	3	.	.	PUNCT
ajbspi-34519	31	1	–	–	PUNCT
ajbspi-34519	31	2	т	т	X
ajbspi-34519	31	3	.	.	NOUN
ajbspi-34519	31	4	17	17	NUM
ajbspi-34519	31	5	.	.	PUNCT
ajbspi-34519	31	6	–	–	PUNCT
ajbspi-34519	31	7	№	№	NOUN
ajbspi-34519	31	8	.	.	NOUN
ajbspi-34519	32	1	2	2	NUM
ajbspi-34519	32	2	.	.	X
ajbspi-34519	32	3	–	–	PUNCT
ajbspi-34519	32	4	с	с	NOUN
ajbspi-34519	32	5	.	.	PROPN
ajbspi-34519	32	6	2329	2329	NUM
ajbspi-34519	32	7	.	.	PUNCT
ajbspi-34519	33	1	2	2	NUM
ajbspi-34519	33	2	.	.	X
ajbspi-34519	33	3	лесниченко	лесниченко	PROPN
ajbspi-34519	33	4	и	и	PROPN
ajbspi-34519	33	5	.	.	PUNCT
ajbspi-34519	34	1	ф	ф	X
ajbspi-34519	34	2	.	.	PUNCT
ajbspi-34519	35	1	и	и	PROPN
ajbspi-34519	35	2	др	др	PROPN
ajbspi-34519	35	3	.	.	PROPN
ajbspi-34519	35	4	клиническое	клиническое	PROPN
ajbspi-34519	35	5	значение	значение	VERB
ajbspi-34519	35	6	уровня	уровня	PROPN
ajbspi-34519	35	7	матриксной	матриксной	NOUN
ajbspi-34519	35	8	металло	металло	PROPN
ajbspi-34519	35	9	-	-	PUNCT
ajbspi-34519	35	10	протеиназы-9	протеиназы-9	PROPN
ajbspi-34519	35	11	(	(	PUNCT
ajbspi-34519	35	12	ммп-9	ммп-9	NUM
ajbspi-34519	35	13	)	)	PUNCT
ajbspi-34519	35	14	в	в	PROPN
ajbspi-34519	35	15	плазме	плазме	PROPN
ajbspi-34519	35	16	аспиратов	аспиратов	PROPN
ajbspi-34519	35	17	костного	костного	PROPN
ajbspi-34519	35	18	мозга	мозга	NOUN
ajbspi-34519	35	19	больных	больных	PROPN
ajbspi-34519	35	20	острым	острым	PROPN
ajbspi-34519	35	21	миелоидным	миелоидным	PROPN
ajbspi-34519	35	22	лейкозом	лейкозом	PROPN
ajbspi-34519	35	23	//вестник	//вестник	PUNCT
ajbspi-34519	35	24	гематологии	гематологии	PROPN
ajbspi-34519	35	25	.	.	PUNCT
ajbspi-34519	36	1	–	–	PUNCT
ajbspi-34519	36	2	2017	2017	NUM
ajbspi-34519	36	3	.	.	PUNCT
ajbspi-34519	37	1	–	–	PUNCT
ajbspi-34519	37	2	т	т	X
ajbspi-34519	37	3	.	.	NOUN
ajbspi-34519	37	4	13	13	NUM
ajbspi-34519	37	5	.	.	PUNCT
ajbspi-34519	37	6	–	–	PUNCT
ajbspi-34519	37	7	№	№	NOUN
ajbspi-34519	37	8	.	.	PUNCT
ajbspi-34519	38	1	3	3	X
ajbspi-34519	38	2	.	.	X
ajbspi-34519	38	3	–	–	PUNCT
ajbspi-34519	38	4	с	с	PROPN
ajbspi-34519	38	5	.	.	PROPN
ajbspi-34519	38	6	49	49	NUM
ajbspi-34519	38	7	-	-	SYM
ajbspi-34519	38	8	49	49	NUM
ajbspi-34519	38	9	.	.	PUNCT
ajbspi-34519	39	1	3	3	X
ajbspi-34519	39	2	.	.	PUNCT
ajbspi-34519	40	1	мамаев	мамаев	PROPN
ajbspi-34519	40	2	н	н	PROPN
ajbspi-34519	40	3	.	.	PUNCT
ajbspi-34519	41	1	н	н	X
ajbspi-34519	41	2	.	.	PUNCT
ajbspi-34519	42	1	и	и	PROPN
ajbspi-34519	42	2	др	др	PROPN
ajbspi-34519	42	3	.	.	PROPN
ajbspi-34519	42	4	молекулярный	молекулярный	PROPN
ajbspi-34519	42	5	мониторинг	мониторинг	PROPN
ajbspi-34519	42	6	течения	течения	PROPN
ajbspi-34519	42	7	острых	острых	PROPN
ajbspi-34519	42	8	миелоидных	миелоидных	NOUN
ajbspi-34519	42	9	лейкозов	лейкозов	VERB
ajbspi-34519	42	10	по	по	ADP
ajbspi-34519	42	11	уровню	уровню	PROPN
ajbspi-34519	42	12	экспрессии	экспрессии	PROPN
ajbspi-34519	42	13	гена	гена	NOUN
ajbspi-34519	42	14	wt1	wt1	VERB
ajbspi-34519	42	15	после	после	NOUN
ajbspi-34519	42	16	аллогенной	аллогенной	ADV
ajbspi-34519	42	17	трансплантации	трансплантации	VERB
ajbspi-34519	43	1	гемопоэтических	гемопоэтических	PROPN
ajbspi-34519	43	2	стволовых	стволовых	PROPN
ajbspi-34519	43	3	клеток	клеток	PROPN
ajbspi-34519	43	4	//клиническая	//клиническая	PUNCT
ajbspi-34519	43	5	онкогематология	онкогематология	PROPN
ajbspi-34519	43	6	.	.	PUNCT
ajbspi-34519	44	1	фундаментальные	фундаментальные	NOUN
ajbspi-34519	44	2	исследования	исследования	PROPN
ajbspi-34519	44	3	и	и	PROPN
ajbspi-34519	44	4	клиническая	клиническая	X
ajbspi-34519	44	5	практика	практика	NOUN
ajbspi-34519	44	6	.	.	PUNCT
ajbspi-34519	45	1	–	–	PUNCT
ajbspi-34519	45	2	2018	2018	NUM
ajbspi-34519	45	3	.	.	PUNCT
ajbspi-34519	46	1	–	–	PUNCT
ajbspi-34519	46	2	т	т	X
ajbspi-34519	46	3	.	.	NOUN
ajbspi-34519	46	4	8	8	NUM
ajbspi-34519	46	5	.	.	X
ajbspi-34519	46	6	–	–	PUNCT
ajbspi-34519	46	7	№	№	NOUN
ajbspi-34519	46	8	.	.	PUNCT
ajbspi-34519	47	1	3	3	X
ajbspi-34519	47	2	.	.	X
ajbspi-34519	47	3	–	–	PUNCT
ajbspi-34519	47	4	с	с	PROPN
ajbspi-34519	47	5	.	.	PUNCT
ajbspi-34519	47	6	309	309	NUM
ajbspi-34519	47	7	-	-	SYM
ajbspi-34519	47	8	320	320	NUM
ajbspi-34519	47	9	.	.	PUNCT
ajbspi-34519	47	10	4	4	NUM
ajbspi-34519	47	11	.	.	PUNCT
ajbspi-34519	47	12	аббасова	аббасова	VERB
ajbspi-34519	47	13	м	м	X
ajbspi-34519	47	14	.	.	PUNCT
ajbspi-34519	48	1	т	т	X
ajbspi-34519	48	2	.	.	PROPN
ajbspi-34519	48	3	,	,	PUNCT
ajbspi-34519	48	4	гаджиев	гаджиев	PROPN
ajbspi-34519	48	5	а	а	PROPN
ajbspi-34519	48	6	.	.	PUNCT
ajbspi-34519	49	1	м	м	X
ajbspi-34519	49	2	.	.	PUNCT
ajbspi-34519	49	3	изменения	изменения	ADJ
ajbspi-34519	49	4	показателей	показателей	PROPN
ajbspi-34519	49	5	обмена	обмена	PROPN
ajbspi-34519	49	6	железа	железа	NOUN
ajbspi-34519	49	7	в	в	PROPN
ajbspi-34519	49	8	крови	крови	PROPN
ajbspi-34519	49	9	крыс	крыс	PROPN
ajbspi-34519	49	10	при	при	PROPN
ajbspi-34519	49	11	электромагнитном	электромагнитном	PROPN
ajbspi-34519	49	12	облучении	облучении	VERB
ajbspi-34519	49	13	в	в	PROPN
ajbspi-34519	49	14	дециметровом	дециметровом	PROPN
ajbspi-34519	49	15	диапазоне	диапазоне	PROPN
ajbspi-34519	49	16	//гематология	//гематология	PUNCT
ajbspi-34519	49	17	и	и	PROPN
ajbspi-34519	49	18	трансфузиология	трансфузиология	NOUN
ajbspi-34519	49	19	.	.	PUNCT
ajbspi-34519	50	1	–	–	PUNCT
ajbspi-34519	50	2	2019	2019	NUM
ajbspi-34519	50	3	.	.	PUNCT
ajbspi-34519	51	1	–	–	PUNCT
ajbspi-34519	51	2	т	т	X
ajbspi-34519	51	3	.	.	NOUN
ajbspi-34519	51	4	64	64	NUM
ajbspi-34519	51	5	.	.	PUNCT
ajbspi-34519	52	1	–	–	PUNCT
ajbspi-34519	52	2	№	№	NOUN
ajbspi-34519	52	3	.	.	PUNCT
ajbspi-34519	53	1	3	3	X
ajbspi-34519	53	2	.	.	X
ajbspi-34519	53	3	–	–	PUNCT
ajbspi-34519	53	4	с	с	PROPN
ajbspi-34519	53	5	.	.	PROPN
ajbspi-34519	53	6	274	274	NUM
ajbspi-34519	53	7	-	-	SYM
ajbspi-34519	53	8	282	282	NUM
ajbspi-34519	53	9	.	.	NOUN
ajbspi-34519	54	1	5	5	NUM
ajbspi-34519	54	2	.	.	X
ajbspi-34519	54	3	аманкулова	аманкулова	PROPN
ajbspi-34519	55	1	а	а	PROPN
ajbspi-34519	55	2	.	.	PUNCT
ajbspi-34519	56	1	а	а	PROPN
ajbspi-34519	56	2	.	.	PROPN
ajbspi-34519	56	3	,	,	PUNCT
ajbspi-34519	56	4	макимбетов	макимбетов	NOUN
ajbspi-34519	56	5	э	э	PROPN
ajbspi-34519	56	6	.	.	PUNCT
ajbspi-34519	57	1	к	к	X
ajbspi-34519	57	2	.	.	PUNCT
ajbspi-34519	58	1	лечение	лечение	PROPN
ajbspi-34519	58	2	острого	острого	NOUN
ajbspi-34519	58	3	лимфобластного	лимфобластного	PROPN
ajbspi-34519	58	4	лейкоза	лейкоза	PROPN
ajbspi-34519	58	5	у	у	PROPN
ajbspi-34519	58	6	детей	детей	NOUN
ajbspi-34519	58	7	на	на	PROPN
ajbspi-34519	58	8	современном	современном	PROPN
ajbspi-34519	58	9	этапе	этапе	PROPN
ajbspi-34519	58	10	(	(	PUNCT
ajbspi-34519	58	11	обзор	обзор	PROPN
ajbspi-34519	58	12	литературы	литературы	NOUN
ajbspi-34519	58	13	)	)	PUNCT
ajbspi-34519	58	14	//вестник	//вестник	PUNCT
ajbspi-34519	58	15	кыргызско	кыргызско	ADJ
ajbspi-34519	58	16	-	-	PUNCT
ajbspi-34519	58	17	российского	российского	NOUN
ajbspi-34519	58	18	славянского	славянского	NOUN
ajbspi-34519	58	19	университета	университета	ADV
ajbspi-34519	58	20	.	.	PUNCT
ajbspi-34519	58	21	–	–	PUNCT
ajbspi-34519	58	22	2020	2020	NUM
ajbspi-34519	58	23	.	.	PUNCT
ajbspi-34519	59	1	–	–	PUNCT
ajbspi-34519	59	2	т	т	X
ajbspi-34519	59	3	.	.	PROPN
ajbspi-34519	59	4	20	20	NUM
ajbspi-34519	59	5	.	.	X
ajbspi-34519	59	6	–	–	PUNCT
ajbspi-34519	59	7	№	№	NOUN
ajbspi-34519	59	8	.	.	NOUN
ajbspi-34519	60	1	1	1	NUM
ajbspi-34519	60	2	.	.	X
ajbspi-34519	60	3	–	–	PUNCT
ajbspi-34519	60	4	с	с	NOUN
ajbspi-34519	60	5	.	.	PROPN
ajbspi-34519	61	1	11	11	NUM
ajbspi-34519	61	2	-	-	SYM
ajbspi-34519	61	3	15	15	NUM
ajbspi-34519	61	4	.	.	PUNCT
ajbspi-34519	62	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-34519	62	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	NOUN
ajbspi-34519	62	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	NOUN